ONK Therapeutics
PrivateLast Round
Series A
Jan 6, 2022
Total Funding Raised
$33.45M
Company Overview
ONK Therapeutics is a biotechnology company that develops next-generation, off-the-shelf, optimally engineered natural killer (NK) cell therapies for the treatment of hematological malignancies and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ONK Therapeutics Comparables
Compare ONK Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoImmune Therapeutics | 89% | |
| NK:IO | 84% | |
| Glycostem Therapeutics | 83% |
ONK Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 6, 2022 | ||||
| Grant | Jun 8, 2021 | ||||
| VC Round | Oct 19, 2020 | ||||
| Seed | May 1, 2020 | ||||
| Grant | Dec 10, 2018 |
ONK Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cormorant Asset Management | Series A |
| Acorn Bioventures | Series A, VC Round |
| Enterprise Ireland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 39% MoM.
- Nov 9, 2025
Monthly visitors increased 46% MoM.
ONK Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ONK Therapeutics's valuation, stock price, and market status.
Is ONK Therapeutics a public or private company?
ONK Therapeutics is a private company.
What is the current stock price of ONK Therapeutics?
ONK Therapeutics is a private company with no public stock price. Caplight tracks ONK Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is ONK Therapeutics worth (valuation)?
Valuation information for ONK Therapeutics is not publicly available.
Can I buy ONK Therapeutics stock?
ONK Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ONK Therapeutics's last funding round?
ONK Therapeutics's most recent funding round was Series A on January 6, 2022.
Who are the main investors in ONK Therapeutics?
Key investors in ONK Therapeutics include Acorn Bioventures.
Will ONK Therapeutics IPO soon?
No public IPO plans have been announced for ONK Therapeutics.
How can I track ONK Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ONK Therapeutics's secondary market activity and sign up for updates.